Patents by Inventor Ildiko Bock-Marquette

Ildiko Bock-Marquette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THYMOSIN Beta4 PEPTIDES PROMOTE TISSUE REGENERATION
    Publication number: 20110251128
    Abstract: The present invention relates to thymosin ?-4 peptides and analogs thereof that can promote tissues regeneration, particularly cardiac tissue.
    Type: Application
    Filed: February 25, 2011
    Publication date: October 13, 2011
    Inventors: ILDIKO BOCK-MARQUETTE, J. MICHAEL DIMAIO
  • METHOD OF TREATING PREVENTING, INHIBITING OR REDUCING DAMAGE TO CARDIAC TISSUE
    Publication number: 20090214507
    Abstract: A method of treatment for treating, preventing, inhibiting or reducing damage to coronary tissue includes inducing at least one of a physiological function selected from: up-regulation of or increasing ILK activity in the coronary tissue, up-regulation of or increasing Akt activity in the coronary tissue, down-regulation of or reducing cardiomyocyte cell death in the coronary tissue and hibernation of cardiomyocytes in the coronary tissue. An induction agent capable of inducing such physiological function in a subject is administered to a subject in need of such treatment.
    Type: Application
    Filed: August 19, 2005
    Publication date: August 27, 2009
    Applicant: RegeneRx Biopharmaceuticals, Inc.
    Inventors: Deepak Srivastava, Ildiko Bock-Marquette, Ankor Saxena, Allan L. Goldstein
  • Screening of agents for activity against ischemic myocardial insults
    Patent number: 7531318
    Abstract: Integrin-linked kinase (ILK) and Akt/protein kinase B (PKB) are important mediators of signaling in cardiomyocytes and can both prevent damage and promote healing associated with ischemic injury to the heart. Thus, the present invention provides for methods of screening for agents that increase the expression of ILK and/or Akt/PKB. Methods of treatment based on such agents are also provided.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: May 12, 2009
    Assignee: Board of Regents, The University of Texas System
    Inventors: Deepak Srivastava, Ildiko Bock-Marquette, Ankur Saxena